Aquestive Therapeutics (AQST) Other Working Capital Changes (2020 - 2021)
Aquestive Therapeutics (AQST) posted quarterly Other Working Capital Changes of $167000.0 for Q1 2021, up 215.97% year-over-year from $52852.7 in Q1 2020, and up 215.97% quarter-over-quarter from -$144000.0 in Q1 2020.
Aquestive Therapeutics (AQST) Other Working Capital Changes (2020 - 2021) Analysis & Trends
Aquestive Therapeutics' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$272000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 35.7% year-over-year to -$272000.0; the TTM figure through Mar 2026 stood at -$1.4 million (up 89.84% YoY), while the FY2025 annual figure was -$571000.0, up 95.55% from the prior year.
- Other Working Capital Changes for Q1 2021 stood at $167000.0, up from -$144000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $167000.0 in Q1 2021, with the low at -$144000.0 in Q1 2020.
- The 5-year median for Other Working Capital Changes is -$272000.0 (2025), against an average of $668764.7.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes jumped 2616.64% in 2022, then sank 1539.6% in 2024.
- Aquestive Therapeutics' Other Working Capital Changes stood at $14.5 million in 2022, then slumped by 110.13% to -$1.5 million in 2023, then surged by 82.28% to -$261000.0 in 2024, then fell by 4.21% to -$272000.0 in 2025, then changed by 0.0% to -$272000.0 in 2026.
- Business Quant data shows AQST's Other Working Capital Changes at -$272000.0 in Q1 2026, -$272000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 167,000.00 |
| Mar 31, 2021 | 167,000.00 |
| Mar 31, 2021 | 167,000.00 |
| Mar 31, 2020 | -144,000.00 |
| Mar 31, 2020 | -144,000.00 |
| Mar 31, 2020 | -144,000.00 |